Treatment
Treatment A clinical trials
We’re tracking 8,310 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT06791148RecruitingPhase 2
Low-dose radiation plus chemo and immunotherapy for advanced stomach cancer
This trial tests a combination of low-dose radiation, chemotherapy, and an immunotherapy drug (AK112) for people with advanced stomach or gastroesophageal junction cancer that has progressed after first-line treatment. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
Nanjing, JiangsuAges 18–75 - NCT05618002Recruiting
Study compares sleep medicines for chronic pain insomnia
This trial tests different treatments to help people with long-term (chronic) pain and severe insomnia sleep better. It’s looking at three options—one medicine (lemborexant) compared with existing sleep medicines (zopiclone and clonidine)—and whether they improve sleep when non-medicine sleep strategies haven’t worked.
Surrey, British ColumbiaAges 20–99 - NCT05864638Recruiting
Registry study of clot-removal treatment for acute stroke
This study records outcomes for people having an acute ischemic stroke treated with an endovascular (catheter-based) procedure. It may help doctors understand how clot-removal treatment works in different patients and hospitals.
ShanghaiAges Any age - NCT06485206Recruiting
Hybrid disc replacement and fusion for two-level neck disease
This study tests a combination of a disc replacement (Mobi-C) and a spinal fusion (ACDF) for people with degenerative disc disease at two levels in the neck. The goal is to see if this approach is safe and effective for relieving pain and nerve symptoms.
Sacramento, CaliforniaAges 22–69 - NCT06794931Recruiting
Mediterranean diet for advanced colorectal cancer during chemo
This study tests whether a modified Mediterranean diet can help people with advanced colorectal cancer who are starting chemotherapy. It aims to see if the diet improves treatment side effects and quality of life.
Vimercate, MBAges 18–80 - NCT06793241RecruitingEarly Phase 1
Donor CAR-T cells for B-cell leukemia
This trial tests whether CAR-T cells made from a healthy donor can help treat B-cell acute lymphoblastic leukemia that has come back or not responded to treatment. It's for adults who cannot use their own cells for CAR-T therapy.
Hangzhou, ZhejiangAges 18 years+ - NCT06793020Recruiting
Study of sepsis-related heart damage using a math model
This trial tests a new mathematical model to better diagnose and treat heart problems caused by sepsis. It includes adults with sepsis or septic shock who need strong blood pressure support.
VilniusAges 18 years+ - NCT07462013Recruiting
Lifestyle changes to prevent memory loss with depression
This study tests if healthy lifestyle changes can protect memory and thinking skills in people with depression who have no or mild memory problems.
Taichung, TaichungAges 50–80 - NCT06794307Recruiting
Blood sugar in pregnant women receiving betamethasone for preterm birth
This study looks at how betamethasone, a steroid given to help babies' lungs mature, affects blood sugar levels in pregnant women without diabetes. It may help ensure safer treatment for women at risk of early labor.
Aarhus, Central Region DenmarkAges 18 years+ - NCT07454837RecruitingPhase 2/Phase 3
Switching to brelovitug for chronic hepatitis D patients on bulevirtide
This trial tests if switching from bulevirtide to brelovitug can help people with chronic hepatitis D (CHD). It is for adults who have been on bulevirtide for at least 6 months and still have detectable virus.
GrazAges 18 years+ - NCT07461454RecruitingPhase 3
Comparing YL202 to other treatments for HR+/HER2- breast cancer
This trial tests a new drug called YL202 against other treatments chosen by your doctor for people with a certain type of advanced breast cancer (HR+/HER2-). It aims to see if YL202 works better. You may join if your cancer has spread, you've already tried chemotherapy, and you meet other health criteria.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07459634RecruitingPhase 2
Combination treatment for extensive-stage small cell lung cancer
This trial tests a combination of two drugs—lurbinectedin and durvalumab—for people with extensive-stage small cell lung cancer who have already received initial treatment. The goal is to see if this combination can help control the cancer better.
Los Angeles, CaliforniaAges 18 years+ - NCT07456696RecruitingPhase 3
TSND-201 for PTSD treatment study
This trial tests if an investigational drug called TSND-201 can help treat PTSD. It is for people who have tried at least one other PTSD treatment before.
Phoenix, ArizonaAges 18 years+ - NCT07459387Recruiting
Real-world results of a new balloon-in-basket pulsed field ablation catheter for atrial fibrillation
This study tracks patients who have atrial fibrillation and receive a new type of ablation therapy using a special balloon that delivers short electrical pulses. It aims to see how well this new device works in everyday medical practice.
FrankfurtAges 18 years+ - NCT07454915RecruitingPhase 2
PVX4 vaccine for HPV16-related cervical dysplasia
This trial tests a new vaccine called PVX4 for women with HPV16-related cervical dysplasia. It aims to see if the vaccine can help clear the high-risk HPV infection and the abnormal cells on the cervix.
The Bronx, New YorkAges 18–60 - NCT07457762Recruiting
Reminder app for pulmonary hypertension inhaler
This study tests if a smartphone app can help people with pulmonary arterial hypertension (PAH) stick to their inhaled iloprost treatment. It is for adults already on this treatment at a specific clinic in Brazil.
São Paulo, São PauloAges 18 years+ - NCT07461545Recruiting
Apixaban for late portal vein clot after spleen surgery
This trial tests if apixaban, a blood thinner, is more effective than aspirin at treating blood clots in the portal vein that form more than a year after laparoscopic spleen removal in people with cirrhosis and an enlarged spleen.
Yangzhou, JiangsuAges 18 years+ - NCT07461818Recruiting
Quick treatment for cervical pre-cancer
This trial tests a new way to quickly diagnose and treat cervical pre-cancer using a point-of-care device. It may help women who are HPV-positive avoid a separate treatment visit.
San Salvador, San Salvador DepartmentAges 30–49 - NCT07457437Recruiting
Exercise and medication for weight loss in women
This study tests whether adding resistance exercise to a new weight-loss medication helps women preserve muscle while losing weight. It may be an option for women who want to protect their muscle mass during treatment.
Exeter, DevonAges 25–50 - NCT07462065RecruitingPhase 4
Clomiphene with or without Pioglitazone for PCOS
This study compares two fertility treatments: clomiphene alone or clomiphene plus pioglitazone. It aims to see if adding pioglitazone improves ovarian stimulation in women with PCOS.
Islamabad, FederalAges 18–38 - NCT07461441RecruitingPhase 3
Personalized faricimab for new polypoidal choroidal vasculopathy
This study tests a personalized treatment plan using an investigational drug called faricimab for people who have a specific type of wet age-related macular degeneration known as polypoidal choroidal vasculopathy. The goal is to see if adjusting the time between injections based on your individual needs can safely dry up fluid in the retina and improve vision.
Daegu, NamguAges 50 years+ - NCT07459790RecruitingPhase 2/Phase 3
A new treatment for interstitial cystitis with Hunner's lesions
This study tests a new treatment for women with interstitial cystitis (also called painful bladder syndrome) who have Hunner's lesions (specific sores in the bladder lining). The goal is to see if the new treatment can reduce pelvic pain, frequent urination, and other symptoms.
MoscowAges 18–65 - NCT07460817Enrolling by invitation
A brief therapy for PTSD called BWRT
This trial tests a short therapy called BWRT (BrainWorking Recursive Therapy) to help people with PTSD. It compares the therapy to a waitlist group to see if it reduces trauma symptoms.
BergenAges 18–65 - NCT07455929Recruiting
Yoga group therapy for schizophrenia
This trial tests whether a yoga-based group program can help people with schizophrenia spectrum disorders feel better. It's designed for outpatients who are stable enough to participate in group therapy.
BerlinAges 18–65
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,310 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.